Fidelity SPDR Advertisement
Home > Boards > Free Zone > Penny Trading - Technical > MOMO'S BREAKOUT BOARD

XCLL ~ Nice bounce after filling the gap!

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
SmallCapsMarket Member Profile
 
Followed By 460
Posts 42,559
Boards Moderated 2
Alias Born 12/21/09
160x600 placeholder
Roche Hit By Failure Of Cancer Drug Trial
Roche said a late-stage study of its breast cancer drug Kadcyla failed to yield superior results to an existing treatment, damaging the outlook for stronger sales in one of its key drug markets.
More Top Equities Stories Of The Day
Deezer Names New CEO Before Full U.S. Launch
Repsol to Buy Talisman Energy for $8.3 Billion --Update
How a Memo Cost Big Banks $37 Billion
Mobile's Rise Poses a Riddle for Banks
Nike Sees Jump in Sales, Growth Concerns -- 4th Update
Sprint to Face Record Fine Over Unauthorized Customer Charges
ADR Shares End Lower; BT Group Shares Trade Actively
Oracle Beats Street View for First Time in a Year
SmallCapsMarket   Tuesday, 05/01/12 10:52:31 AM
Re: VIDAO post# 897368
Post # of 1471536 
Compensated Awareness Post - View Disclaimer
XCLL ~ Nice bounce after filling the gap!




As Always: My Number 1 Priority is to educate. Penny stocks are very volatile, Always do your own Due Diligence
Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist